Search results
If You Invested $1000 in Halozyme Therapeutics a Decade Ago, This is How Much It'd Be Worth Now
Zacks via Yahoo News· 3 weeks agoFor most investors, how much a stock's price changes over time is important. This factor can impact...
AbbVie to buy drug developer Cerevel for $8.7 billion
Reuters via Yahoo News· 8 months agoIt marks the second large deal for AbbVie in the past week, coming days after it agreed to buy...
AbbVie (ABBV) Lymphoma Drug Gets FDA Breakthrough Therapy Tag
Zacks via Yahoo News· 8 months agoThe FDA grants breakthrough therapy designation to AbbVie's (ABBV) Epkinly in follicular lymphoma...
Data breach at medical giant Cencora exposes info from multiple drug companies
TechRadar via Yahoo News· 2 months agoHealthcare. Almost a dozen pharmaceutical companies, including several major players, have lost...
Here's Why Eli Lilly (LLY) is Probably the Best Drug Stock Now
Zacks via Yahoo News· 1 month agoStocks of pharma companies, particularly large ones, make excellent defensive investments in an...
AbbVie (ABBV) Q4 Earnings Beat, Raises Sales View for Key Drugs
Zacks via Yahoo News· 6 months agoAbbVie???s (ABBV) fourth-quarter earnings and sales beat estimates. Management hikes the 2027...
AbbVie (ABBV) Up 24% in a Year: Buy, Sell or Hold the Stock?
Zacks via Yahoo News· 3 weeks agoInvestors who own AbbVie's (ABBV) stock may stay invested as the company has faced its biggest...
3 Generic Drug Stocks to Watch Amid Improving Market Prospects
Zacks via Yahoo News· 3 weeks agoWith the ease in inflationary pressure, the Zacks Medical - Generic Drugs industry is expected to...
Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, AbbVie and Novartis
Zacks via Yahoo News· 6 months agoFor Immediate Release Chicago, IL – February 5, 2024 – Today, Zacks Equity Research discusses Eli...
Biden Administration targets drugs from J&J, Merck for controversial Medicare price negotiations
Yahoo Finance· 11 months agoThe Biden Administration this morning revealed the first 10 drugs for which Medicare will negotiate...